Fig. 1: The principle of the functional precision oncology (fPO) pipeline. | British Journal of Cancer

Fig. 1: The principle of the functional precision oncology (fPO) pipeline.

From: Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma

Fig. 1

Patient-derived cancer cells (PDCs) established from HGSOC, LGSOC and MUCOC tumour or ascites samples were subjected to molecular characterisation and functional drug testing platform covering up to 526 drugs to identify patient-selective drug vulnerabilities that can be translated back to the clinics in real-time. Figure was created with BioRender.com.

Back to article page